AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33906853 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 269
Study 33906853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 33906853 — intervention group
Group type: COMPARATOR
Intervention: Placebo→Tofacitinib
Number of subjects: 269
Study 36154509 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD)
Number of subjects: 124
Study 36154509 — intervention group
Group type: COMPARATOR
Intervention: Intratympanic lidocaine (ITL)
Number of subjects: 124
Study 36154509 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD2, 5 mg/ml)
Number of subjects: 124
Study 36154509 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD1, 2 mg/ml)
Number of subjects: 124
Study 32171800 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 hours of fasting
Number of subjects: 3
Study 32171800 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 hours of fasting followed by 1 hour of refeeding
Number of subjects: 3
Study 32171800 — intervention group
Group type: COMPARATOR
Intervention: Control (fed)
Number of subjects: 3
Study 34425422 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management training program (delivered by physical therapy doctoral students, 6-week duration)
Number of subjects: 38
Study 34425422 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management training program
Number of subjects: 38
Study 32503465 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 100
Study 32503465 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 100
Study 32503465 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT and MICT
Number of subjects: 100
Study 36119666 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-component and multifactorial personalized intervention
Number of subjects: 403
Study 36119666 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 403
Study 32672669 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil/Latanoprost FDC
Number of subjects: 750
Study 32672669 — intervention group
Group type: COMPARATOR
Intervention: Netarsudil
Number of subjects: 750
Study 32672669 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 750
Study 35775676 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine injection
Number of subjects: 120
Study 35775676 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bupivacaine injection)
Number of subjects: 120
Study 33707520 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during surgery
Number of subjects: 84
Study 33707520 — intervention group
Group type: COMPARATOR
Intervention: No music intervention (control group)
Number of subjects: 84
Study 34535967 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 12 months
Number of subjects: 82
Study 34535967 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 180 mg every 6 months for 12 months
Number of subjects: 82
Study 34535967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 34535967 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (both dosages)
Number of subjects: 82
Study 32833167 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatekeeper training
Number of subjects: 0
Study 32833167 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainee participation
Number of subjects: 0
Study 32833167 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainer engagement
Number of subjects: 0
Study 36124755 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Language‐Action Therapy combined with standard care
Number of subjects: 60
Study 36124755 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study 34533295 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification strategy intervention
Number of subjects: 2197
Study 34533295 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2197
Study 33934062 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year PA intervention that encouraged neighborhood walking
Number of subjects: 305
Study 33934062 — intervention group
Group type: COMPARATOR
Intervention: Healthy aging control condition
Number of subjects: 305
Study 32052777 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated placement
Number of subjects: 29
Study 32052777 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinical placement
Number of subjects: 29
Study 35451681 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) syndrome differentiation
Number of subjects: 96
Study 35451681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 34341980 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR documentation burden
Number of subjects: 1096
Study 34341980 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR burden
Number of subjects: 1096
Study 34341980 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with jobs
Number of subjects: 1096
Study 34341980 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with careers
Number of subjects: 1096
Study 34341980 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with lives
Number of subjects: 1096
Study 34341980 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-life balance challenges
Number of subjects: 1096
Study 32604148 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodization (DUP)
Number of subjects: 41
Study 32604148 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonperiodized Training (NPT)
Number of subjects: 41
Study 32604148 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 41
Study 33852013 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60% of total energy)
Number of subjects: 70
Study 35319310 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 1582
Study 35319310 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1582
Study 34164939 — intervention group
Group type: EXPERIMENTAL
Intervention: Various mental health interventions including Cognitive Behaviour Therapy, psychosocial approaches, group-based and family strengthening interventions, economic empowerment combined with family strengthening, group-based mindfulness, and community interventions.
Number of subjects: 13
Study 34164939 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional mental health treatments and psychosocial interventions.
Number of subjects: 13
Study 34164939 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained lay counsellors as facilitators.
Number of subjects: 13
Study 34164939 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized control trials and pilot studies.
Number of subjects: 13
Study 35922093 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet compress combined with chitosan wound dressing
Number of subjects: 80
Study 35922093 — intervention group
Group type: COMPARATOR
Intervention: Wet compress
Number of subjects: 80
Study 33482888 — intervention group
Group type: EXPERIMENTAL
Intervention: TESI combined with levobupivacaine added to oral pain medication
Number of subjects: 3
Study 33482888 — intervention group
Group type: COMPARATOR
Intervention: Oral pain medication alone
Number of subjects: 3
Study 33482888 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal epidural injection with levobupivacaine and saline solution added to oral pain medication
Number of subjects: 3
Study 33482888 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral pain medication alone)
Number of subjects: 3
Study 33482888 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 3
Study 35435194 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone combined with oxybuprocaine hydrochloride gel (G group)
Number of subjects: 60
Study 35435194 — intervention group
Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 60
Study 33916810 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-item questionnaire
Number of subjects: 839
Study 35507446 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) continuation
Number of subjects: 60
Study 35507446 — intervention group
Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIg) withdrawal
Number of subjects: 60
Study 35507446 — intervention group
Group type: EXPERIMENTAL
Intervention: MCID cut-offs for I-RODS and MRC-SS
Number of subjects: 60
Study 32593791 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 22
Study 32593791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 32631102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to promote handwashing with soap
Number of subjects: 14
Study 34109590 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation training on the basis of routine drug therapy
Number of subjects: 100
Study 34109590 — intervention group
Group type: COMPARATOR
Intervention: Routine medication
Number of subjects: 100
Study 36191597 — intervention group
Group type: EXPERIMENTAL
Intervention: Polycaprolactone injection
Number of subjects: 80
Study 36191597 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate gel injection
Number of subjects: 80
Study 33516674 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition-enhancing medications
Number of subjects: 1135
Study 33516674 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid medications
Number of subjects: 1135
Study 33516674 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medications
Number of subjects: 1135
Study 33131315 — intervention group
Group type: EXPERIMENTAL
Intervention: High office blood pressure variability (OBPV) - highest tertile
Number of subjects: 16475
Study 35803619 — intervention group
Group type: EXPERIMENTAL
Intervention: Biophilic VR
Number of subjects: 600
Study 35803619 — intervention group
Group type: COMPARATOR
Intervention: Sham VR
Number of subjects: 600
Study 34186056 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 97
Study 34186056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 36031273 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-punitive performance feedback via weekly text messages about driving score and rank
Number of subjects: 1393
Study 32074474 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure electronic messaging
Number of subjects: 73
Study 32074474 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician responses based on patients' demographics
Number of subjects: 73
Study 32074474 — intervention group
Group type: EXPERIMENTAL
Intervention: Message content analysis
Number of subjects: 73
Study 36715629 — intervention group
Group type: EXPERIMENTAL
Intervention: Ostomy baseplate with skin-protection technology
Number of subjects: 79
Study 36715629 — intervention group
Group type: COMPARATOR
Intervention: Comparator product (SenSura® Mio)
Number of subjects: 79
Study 32031757 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for conversion disorder/functional neurological disorder (CD/FND)
Number of subjects: 64
Study 32031757 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid depression treatment
Number of subjects: 64
Study 36253729 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard volume ESPB with 20 ml 0.25% bupivacaine
Number of subjects: 60
Study 36253729 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume ESPB with 40 ml 0.125% bupivacaine
Number of subjects: 60
Study 36253729 — intervention group
Group type: COMPARATOR
Intervention: GA only group (control)
Number of subjects: 60
Study 36253729 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume ESPB
Number of subjects: 60
Study 36253729 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard volume ESPB
Number of subjects: 60
Study 36253729 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ESPB groups
Number of subjects: 60
Study 32513562 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-delivered relaxation massage
Number of subjects: 27
Study 32513562 — intervention group
Group type: COMPARATOR
Intervention: Self-directed stress management
Number of subjects: 27
Study 32907752 — intervention group
Group type: COMPARATOR
Intervention: G0 (0 days pH cycling)
Number of subjects: 96
Study 32907752 — intervention group
Group type: EXPERIMENTAL
Intervention: G14 (14 days pH cycling)
Number of subjects: 96
Study 32907752 — intervention group
Group type: EXPERIMENTAL
Intervention: G21 (21 days pH cycling)
Number of subjects: 96
Study 35410367 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoptic therapy (at least 2 months) including anti-suppression, vergence, and accommodation training
Number of subjects: 136
Study 35410367 — intervention group
Group type: COMPARATOR
Intervention: Blank control (only refractive correction)
Number of subjects: 136
Study 35410367 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoptic therapy
Number of subjects: 136
Study 35410367 — intervention group
Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 136
Study 33606764 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane-based inhalational anesthesia
Number of subjects: 68
Study 33606764 — intervention group
Group type: COMPARATOR
Intervention: Propofol-based TIVA
Number of subjects: 68
Study 32407239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 32407239 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined histamine H1/H2-receptor antagonists (Blockade)
Number of subjects: 16
Study 32407239 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockade
Number of subjects: 16
Study 33959852 — intervention group
Group type: EXPERIMENTAL
Intervention: Active oral orthotic (occlusal splint)
Number of subjects: 13
Study 33959852 — intervention group
Group type: COMPARATOR
Intervention: Sham orthotic
Number of subjects: 13
Study 34941917 — intervention group
Group type: COMPARATOR
Intervention: Control facial expression manipulation after self-focus
Number of subjects: 0
Study 34941917 — intervention group
Group type: EXPERIMENTAL
Intervention: Smiling facial expression manipulation after self-focus
Number of subjects: 0
Study 34941917 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial expressions after other-focus manipulation
Number of subjects: 0
Study 35877927 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin (AT) supplementation (n = 213)
Number of subjects: 425
Study 35877927 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 212)
Number of subjects: 425
Study 35877927 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin (AT) supplementation
Number of subjects: 425
Study 35877927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 425
Study 33541117 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 1471
Study 33541117 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 1471
Study 33541117 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 1471
Study 32758379 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Arthroscopy after TKA (TKA + KA group)
Number of subjects: 192
Study 32758379 — intervention group
Group type: COMPARATOR
Intervention: No Knee Arthroscopy after TKA (TKA - KA group)
Number of subjects: 192
Study 35881051 — intervention group
Group type: EXPERIMENTAL
Intervention: Belumosudil (200 mg)
Number of subjects: 34
Study 35881051 — intervention group
Group type: EXPERIMENTAL
Intervention: Belumosudil (1000 mg)
Number of subjects: 34
Study 35881051 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 34
Study 35881051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 34028830 — intervention group
Group type: EXPERIMENTAL
Intervention: NAFLD (non-alcoholic fatty liver disease) defined by a fatty liver index score of 60 or more in people without excessive alcohol intake or viral hepatitis.
Number of subjects: 705
Study 34028830 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic risk factors associated with NAFLD
Number of subjects: 705
Study 34028830 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum alanine aminotransferase levels
Number of subjects: 705
Study 34028830 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver stiffness measurements
Number of subjects: 705
Study 32391862 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted antimicrobial stewardship intervention
Number of subjects: 25
Study 32391862 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 25
Study 35364385 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 32
Study 35364385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34131048 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide plus Metformin (LIRA+MET)
Number of subjects: 358
Study 34131048 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 358
Study 34131048 — intervention group
Group type: EXPERIMENTAL
Intervention: Glargine followed by Metformin (G-MET)
Number of subjects: 358
Study 34131048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 358
Study 32132348 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mononuclear cell (BM‐MNC) implantation
Number of subjects: 27
Study 32132348 — intervention group
Group type: COMPARATOR
Intervention: Internal controls
Number of subjects: 27
Study 32132348 — intervention group
Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 27
Study 36096832 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting MACE
Number of subjects: 1206
Study 33743659 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA) injection
Number of subjects: 41
Study 33743659 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 41
Study 33743659 — intervention group
Group type: COMPARATOR
Intervention: Condom use
Number of subjects: 41
Study 33743659 — intervention group
Group type: COMPARATOR
Intervention: Contraception and condom use
Number of subjects: 41
Study 34132512 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 14
Study 34132512 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 14
Study 34134029 — intervention group
Group type: COMPARATOR
Intervention: High stress level in FGIDs population
Number of subjects: 0
Study 34134029 — intervention group
Group type: COMPARATOR
Intervention: Stress as an independent predictor
Number of subjects: 0
Study 34134029 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressor 'changes'
Number of subjects: 0
Study 34134029 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressor 'frustration'
Number of subjects: 0
Study 34134029 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressor 'physiological reaction'
Number of subjects: 0
Study 34134029 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple gastrointestinal symptoms
Number of subjects: 0
Study 34134029 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation effect of stress
Number of subjects: 0
Study 34541744 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-octave pure tone sound therapy based on tinnitus characteristics
Number of subjects: 92
Study 34541744 — intervention group
Group type: COMPARATOR
Intervention: 9 one-third octave pure tone sound therapy based on tinnitus characteristics
Number of subjects: 92
Study 36482335 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic CT enabled planning (Arm 2)
Number of subjects: 33
Study 36482335 — intervention group
Group type: COMPARATOR
Intervention: Conventional CT simulation (Arm 1)
Number of subjects: 33
Study 32244296 — intervention group
Group type: COMPARATOR
Intervention: Enzyme Replacement Therapy (ERT)
Number of subjects: 0
Study 32244296 — intervention group
Group type: EXPERIMENTAL
Intervention: Substrate Reduction Therapy (SRT)
Number of subjects: 0
Study 32244296 — intervention group
Group type: COMPARATOR
Intervention: Untreated (UT)
Number of subjects: 0
Study 33709889 — intervention group
Group type: EXPERIMENTAL
Intervention: Matching-Adjusted Indirect Comparisons for hematological and oncological treatments
Number of subjects: 13
Study 32730561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management with antibiotics (n=370)
Number of subjects: 1068
Study 32730561 — intervention group
Group type: COMPARATOR
Intervention: Urgent laparoscopic appendectomy (n=698)
Number of subjects: 1068
Study 35393360 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg indobufen two times daily
Number of subjects: 200
Study 35393360 — intervention group
Group type: COMPARATOR
Intervention: 100 mg aspirin once daily
Number of subjects: 200
Study 34007245 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual wellbeing assessment using the Functional Assessment of Chronic Illness Therapy‐Spiritual Well‐Being Scale‐12
Number of subjects: 367
Study 34007245 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and clinical factors (place of residence, marital status, educational level, comorbidities)
Number of subjects: 367
Study 32915892 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5mg for 2 weeks/10mg for 10 weeks)
Number of subjects: 51
Study 32915892 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (90mg for 2 weeks/180mg for 10 weeks)
Number of subjects: 51
Study 32915892 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Combination (2.5mg + 45mg for 2 weeks/5mg + 90mg for 10 weeks)
Number of subjects: 51
Study 35753968 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stabilising exercises performed three times per week for 4 weeks in addition to cardiac rehabilitation.
Number of subjects: 36
Study 34776169 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley maneuver
Number of subjects: 36
Study 34776169 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley maneuver and Cawthorne-Cooksey vestibular exercises
Number of subjects: 36
Study 36137957 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS combined with cognitive training
Number of subjects: 60